Cornerstone completes merger with Critical Therapeutics -
CRTX: Completes Merger w.Cornerstone BioPharma -
Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics -
BRIEF-Critical Therapeutics announces stockholder approvals -
Stock deal is key to Cornerstone's future -
Cornerstone Therapeutics, Inc. Taps Josh Franklin to Head Marketing Team -
Critical Therapeutics Stays Sub-$1 -
Critical Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2008 -
Cornerstone BioPharma Holdings, Inc. Welcomes David Price as CFO -
Critical Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2008 -
CRTX: Q2 Earnings Call @ 17:00 ET Today [delayed] -
Critical Therapeutics to Report Second Quarter 2008 Financial Results on August 11 -
CRTX: To Transfer Listing from NASDAQ Global Market to NASDAQ Capital Market -
Critical Therapeutics reports encouraging results from Phase II asthma trial -
CRTX: Announces Results of Ph II Trial of Injectable Formulation of Zileuton -